This week, researchers from across the globe gathered together at the world’s largest MS research conference. One of the hot topics at the conference was Epstein-Barr virus (EBV) – a common type of herpes virus.
A new study from the University of Edinburgh shows myelin-making cells have different characteristics depending on where they are in the body. This could explain why myelin repair is so variable, even within one person.
Several previous studies suggested experiencing depression when you have MS could be linked to increased disability later on. But a new paper from the UK MS Register hasn’t found any evidence to support that.
A recent clinical trial, called the VIDAMS trial, tested whether high dose vitamin D could help treat people with relapsing remitting MS. In a paper published last week, results showed no effect of the supplement on relapses or new lesions on an MRI scan.
We’re excited to announce the new clinical trial we're funding, Octopus, has started recruitment at its first hospital site in London. This means the first few people with primary and secondary progressive MS have begun taking part.
A recent study using the UK MS Register found less than a third of people with MS have been offered a treatment for fatigue as part of their routine care. We’ve committed to raise funds for a new project to help address this.
91 results found
Join the Research Network
Our Research Network make sure all the research we fund reflects the needs and interests of people living with MS. And they help us talk about it in a way that’s accessible to everyone.
Anyone who lives with MS or cares for someone who does can get involved. It doesn't matter where in the UK you live or how much research experience you have.